Search - tctmd.com

Displaying 581 - 600 of 810

Sort: Relevancy | Date

Presentation TCT 2017

Case Introduction: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk

Presenter: Fazila T. Malik, Jack Wei Chieh Tan, Sodiqur Rifqi

October 29, 2017

Presentation TCT 2017

New Insights Into Physiology-Guided PCI for Complex Lesions

Presenter: Takeshi Kimura, Shigeru Saito, Yoshiaki Kawase

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Think Twice: BRS First

Presenter: George D. Dangas, Fabio Felice Tarantino, Francesco Saia

November 01, 2016

Presentation TCT 2016

Choose a Drug-Eluting Stent: Heres Why

Presenter: George D. Dangas, Fabio Felice Tarantino, Carlo Cernetti

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Vladimir Ganyukov

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Presenter: Ik-Kyung Jang, Matthew J. Price, Seung-Jung Park

October 31, 2016

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Italy Presents: How I Managed This Case

Presenter: Ariel Finkelstein, Ugo Limbruno, Giovanni Esposito

October 31, 2016

Presentation TCT 2016

Case Presentation: Difficult DAPT Duration Decision After PCI

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Marcelo Bettinotti

October 31, 2016

Presentation TCT 2016

How to Treat Diffuse Disease With Current PCI Devices

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Presenter: Seung-Jung Park, Alan C. Yeung, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Italy Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno

October 31, 2016

Presentation TCT 2016

Israel Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno, Haim Danenberg

October 31, 2016

Presentation TCT 2016

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gennaro Sardella

October 31, 2016

Advertisement

Case Introduction: A Complex Left Main Distal Bifurcation Stenosis in a Patient at High Surgical Risk

New Insights Into Physiology-Guided PCI for Complex Lesions

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Case Conclusion: How Did We Treat Our Patient?

Think Twice: BRS First

Choose a Drug-Eluting Stent: Heres Why

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Italy Presents: How I Managed This Case

Case Presentation: Difficult DAPT Duration Decision After PCI

How to Treat Diffuse Disease With Current PCI Devices

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Italy Responds: How Would I Treat?

Israel Responds: How Would I Treat?

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content